Estimating Lead Time and Sensitivity in a Screening Program without Estimating the Incidence in the Screened Group
From MaRDI portal
Publication:4350021
DOI10.2307/2533109zbMath0874.62137OpenAlexW2096498044WikidataQ73331816 ScholiaQ73331816MaRDI QIDQ4350021
Petronella G. M. Peer, Huub Straatman, André L. M. Verbeek
Publication date: 9 November 1997
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.2307/2533109
Related Items (5)
A Stochastic Model for Calibrating the Survival Benefit of Screen-Detected Cancers ⋮ Bayesian Inference for the Lead Time in Periodic Cancer Screening ⋮ Estimating distribution of the age of onset of detectable asymptomatic cancer ⋮ Nonparametric Estimation of Asymptomatic Duration from a Randomized Prospective Cancer Screening Trial ⋮ MLE and Bayesian Inference of Age-Dependent Sensitivity and Transition Probability in Periodic Screening
This page was built for publication: Estimating Lead Time and Sensitivity in a Screening Program without Estimating the Incidence in the Screened Group
